查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828178

2025年全球轉染試劑和設備市場報告

Transfection Reagents And Equipment Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，轉染試劑和儀器市場呈現強勁成長勢頭，市場規模從2024年的15.8億美元成長至2025年的17.4億美元，複合年成長率達9.8%。預測期內的成長歸因於生物醫學研究、藥物開發、日益成長的生物技術應用、學術研究機構以及基因工程技術的進步。

預計未來幾年轉染試劑和設備市場將快速成長，到2029年將達到26.6億美元，複合年成長率為11.2%。預測期內的成長歸因於基因治療的進步、生物製造需求的不斷成長、新興的細胞療法、個人化醫療的研發以及全球研究合作。預測期內的主要趨勢包括：對初代細胞轉染的關注、向電穿孔技術的轉變、奈米技術在轉染中的應用、對無動物源轉染試劑的需求不斷成長，以及自動化和高性能轉染系統。

轉染試劑是用於將外來遺傳物質（例如 DNA 或 RNA）導入細胞的物質或套件。這些試劑有助於將核酸遞送到細胞中，在研究人員探索基因表現、調控基因功能和生產重組蛋白方面發揮重要作用。

在轉染試劑和設備領域，主要類別包括儀器、試劑和套件。轉染設備是專門設計的實驗室設備，用於在轉染過程中有效地將外來核酸（例如 DNA 或 RNA）遞送到細胞中。所涉及的分子包括質體DNA、DNA 寡核苷酸、小干擾 RNA (siRNA)、蛋白質和核糖核蛋白複合物 (RNP)。多種生物體，包括細菌、哺乳動物細胞、真菌、植物和病毒，都可以作為這些分子的受體。這些產品適用於各種最終用戶，包括生物製藥公司、委外研發機構(CRO)、合約製造組織 (CMO)、合約研究、開發和製造組織 (CDMO)、大學、醫院和臨床實驗室。

2025年春季美國關稅突然上調及其引發的貿易摩擦，對醫療設備領域產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供轉染試劑和儀器市場統計數據，例如全球市場規模、各地區佔有率、競爭對手的市場佔有率、詳細的轉染試劑和儀器細分市場、市場趨勢以及轉染試劑和儀器行業的商機，為您提供在轉染試劑和儀器行業取得成功所需的數據。本轉染試劑和儀器市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供全面觀點所需的一切。

未來五年的預測成長率為11.2%，較我們先前對該市場的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。這可能會英國影響美國，導致來自英國和新加坡等主要地區的脂質奈米顆粒和電穿孔比色皿供應鏈中斷，這可能導致基因治療研發的延遲。此外，由於互惠關稅以及貿易緊張局勢和限制措施加劇對全球經濟和貿易的負面影響，這種影響可能會更加廣泛地顯現出來。

全球癌症發生率的上升預計將推動轉染試劑和儀器市場的擴張。癌症是指細胞異常且不受控制的增生。轉染試劑在質體研究中發揮著至關重要的作用，它使研究人員能夠透過引入外來遺傳物質（如質粒 DNA 和 RNA 分子）來研究癌症生物學的各個方面，包括基因基因表現研究、基因靜默、藥物篩檢和標靶檢驗。例如，美國非營利組織美國癌症協會於 2024 年 4 月報告稱，2022 年將新增 2,000 萬例癌症病例，並將有 970 萬人死亡。因此，全球癌症患者數量的增加正在刺激轉染試劑和儀器市場的成長。

醫療保健支出的成長趨勢預計將在短期內推動轉染試劑和儀器市場的成長。醫療保健支出包括與提供醫療服務、計劃生育活動、營養計劃和以健康為重點的緊急援助有關的所有費用。醫療保健支出的增加導致研發投資的增加，從而推動了對轉染試劑和儀器的需求，因為它們是推動基因研究、基因治療和生物製藥開發的重要工具。例如，截至 2023 年 6 月，美國聯邦機構醫療保險和醫療補助服務中心報告稱，到 2021 年，美國的醫療保健支出將增加 2.7%，達到 4.3 兆美元，即人均 12,914 美元。這項支出佔國內生產總值的 18.3%。因此，醫療保健支出的快速成長正在推動轉染試劑和儀器市場的成長。

產品創新是推動轉染試劑和儀器市場發展的突出趨勢，主要企業專注於策略性地開發原創產品以保持其市場地位。例如，總部位於法國的生技公司Polyplus-Transfection SA於2022年9月推出了in vivo-jet-RNA+轉染試劑。這款新產品利用預製脂質體製劑進行體內mRNA遞送，是一種高效且可擴展的基因遞送系統，能夠將mRNA遞送送到多種組織和細胞類型中。該試劑安全且耐受性良好，無需配製步驟，其穩定的脂質體尺寸允許mRNA濃度隨時間變化。其治療包括預防性疫苗接種、mRNA療法（用於癌症治療、罕見疾病等）以及基因編輯。

轉染試劑和設備市場的主要企業正在加緊努力推出創新產品線。美國生技公司Mirus Bio LLC於2022年8月推出其TransIT-VirusGEN GMP產品線，體現了這項做法。此產品線專為高效、可擴展的病毒載體轉染而設計，並支援基因治療應用的GMP生產流程。 TransIT-VirusGEN GMP轉染試劑專用腺結合病毒(AAV)和慢病毒載體的大規模治療性生產，可作為多種產品（包括細胞、基因和組織工程產品）的輔助材料，符合USP <1043標準。其主要目標是幫助生物製藥製造商應對與有效且經濟地生產符合商業性可行性要求的品質和數量的AAV和LV載體相關的挑戰。

2023年3月，德國分析儀器製造商賽多利斯公司（Sartorius AG）以26億美元收購了Polyplus-Transfection SA。此次收購使賽多利斯公司在快速擴張的細胞和基因治療市場中佔據了有利地位，支持其業務成長並滿足日益成長的細胞和基因治療需求。 Polyplus-Transfection SA是一家法國生物技術公司，專注於轉染試劑和儀器的開發。

轉染試劑和設備市場的主要企業包括 Thermo Fisher Scientific Inc.、Promega Corporation、Qiagen NV、Bio-Rad Laboratories Inc.、Maxcyte Inc.、Lonza Group Ltd.、Merck KGaA、Mirus Bio LLC、OriGene Technologies Inc.、PromoCell GmbH、Perkinerial Inc.、Alkin Technologies Inc. Ltd.、Sartorius AG、Takara Bio Inc.、Tecan Trading AG、Polyplus-transfection SA、Sigma-Aldrich Corporation、Hoffmann-La Roche Ltd.、Transfection Technologies Inc.、Viromer、ABM Inc.、Bio-Techne Corporation、BIoTium Inc.、Cell Applications Inc.、Genchemel、Hkaks、Hun​​ions Gmbent、Hendakes Bioscience GmbH。

2024年，北美是轉染試劑和儀器市場最大的地區。預計亞太地區將成為預測期內成長最快的地區。轉染試劑和儀器市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美以及中東和非洲。

轉染試劑和設備市場報告涵蓋的國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、美國、英國、加拿大、義大利、西班牙

轉染試劑和設備市場包括脂質體轉染試劑、陽離子聚合物轉染試劑、磷酸鈣轉染試劑、病毒遞送工具、轉染對照質體、轉染檢驗工具和電穿孔系統的銷售。該市場的價值是指“出廠價”，即商品製造商或創造者銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場商品的價值還包括創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球轉染試劑與設備：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球轉染試劑和儀器市場：成長率分析
  • 全球轉染試劑與儀器市場表現：規模與成長，2019-2024
  • 全球轉染試劑與儀器市場預測：規模與成長，2024-2029，2034
  • 全球轉染試劑與儀器：總目標市場（TAM）

第6章 市場細分

  • 全球轉染試劑和儀器市場（按產品、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 裝置
  • 試劑和套件
  • 全球轉染試劑和儀器市場（按分子類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 質體DNA
  • DNA寡核苷酸
  • 小干擾RNA（SiRNA）
  • 蛋白質
  • 核糖核蛋白複合體（RNP）
  • 其他
  • 全球轉染試劑和儀器市場（按生物學、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 細菌
  • 哺乳動物細胞
  • 真菌
  • 植物
  • 病毒
  • 全球轉染試劑和儀器市場（按最終用戶、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 生物製藥
  • 合約研究組織（CRO）
  • 契約製造組織 (CMO) 和合約開發和製造組織 (CDMO)
  • 學術界
  • 醫院
  • 臨床實驗室
  • 其他
  • 全球轉染試劑和儀器市場：儀器細分、類型、性能和預測（2019-2024 年、2024-2029 年、2034 年）
  • 電穿孔系統
  • 顯微注射系統
  • 粒子撞擊系統
  • 其他
  • 全球轉染試劑和儀器市場：試劑和套件細分、類型、性能和預測（2019-2024 年、2024-2029 年、2034 年）
  • 脂質轉染試劑
  • 以聚合物為基礎的轉染試劑
  • 基於蛋白質的轉染試劑
  • 核酸遞送試劑套件
  • 其他

第7章 區域和國家分析

  • 全球轉染試劑和儀器市場：按地區、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 全球轉染試劑及儀器市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 轉染試劑與儀器市場：競爭格局
  • 轉染試劑和儀器市場：公司簡介
    • Thermo Fisher Scientific Inc.
    • Promega Corporation
    • Qiagen NV
    • Bio-Rad Laboratories Inc.
    • Maxcyte Inc.

第31章：其他領先和創新企業

  • Lonza Group Ltd.
  • Merck KGaA
  • Mirus Bio LLC
  • OriGene Technologies Inc.
  • PromoCell GmbH
  • PerkinElmer Inc.
  • Agilent Technologies Inc.
  • Altogen Biosystems
  • Applied Biological Materials Inc.
  • Bex Co. Ltd.
  • Sartorius AG
  • Takara Bio Inc.
  • Tecan Trading AG
  • Polyplus-transfection SA
  • Sigma-Aldrich Corporation

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年轉染試劑和儀器市場：提供新機會的國家
  • 2029年轉染試劑和儀器市場：細分市場帶來新機會
  • 2029年轉染試劑與儀器市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r24564u

Transfection reagents are substances or kits employed for introducing foreign genetic material, such as DNA or RNA, into cells. These reagents play a crucial role in facilitating the delivery of nucleic acids into cells, enabling researchers to explore gene expression, manipulate gene function, or produce recombinant proteins.

Within the realm of transfection reagents and equipment, the primary categories encompass instruments and reagents, along with kits. Transfection instruments are specialized laboratory tools designed to streamline the delivery of foreign nucleic acids, such as DNA or RNA, into cells during the transfection process. The range of molecules involved includes plasmid DNA, DNA oligonucleotides, small interfering RNA (siRNA), proteins, ribonucleoprotein complexes (RNPs), and others. Various organisms, including bacteria, mammalian cells, fungi, plants, and viruses, serve as recipients for these molecules. These products find application across diverse end-users, including biopharma, contract research organizations (CROs), contract manufacturing organizations (CMOs), contract development and manufacturing organizations (CDMOs), academia, hospitals, clinical labs, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The transfection reagents and equipment market research report is one of a series of new reports from The Business Research Company that provides transfection reagents and equipment market statistics, including transfection reagents and equipment industry global market size, regional shares, competitors with a transfection reagents and equipment market share, detailed transfection reagents and equipment market segments, market trends, and opportunities, and any further data you may need to thrive in the transfection reagents and equipment industry. This transfection reagents and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The transfection reagents and equipment market size has grown strongly in recent years. It will grow from $1.58 billion in 2024 to $1.74 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to biomedical research demand, pharmaceutical development, rise in biotechnology applications, academic and research institutions, genetic engineering advancements.

The transfection reagents and equipment market size is expected to see rapid growth in the next few years. It will grow to $2.66 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to gene therapy advancements, increasing bioproduction needs, emerging cell-based therapies, r&d in personalized medicine, global collaborations. Major trends in the forecast period include focus on primary cell transfection, shift towards electroporation techniques, integration of nanotechnology in transfection, increasing demand for animal-free transfection reagents, automation and high-throughput transfection systems.

The forecast of 11.2% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for lipid nanoparticles and electroporation cuvettes, sourced from key regions such as the United Kingdom and Singapore, could lead to research delays in gene therapy development.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing global incidence of cancer is expected to drive the expansion of the transfection reagents and equipment market. Cancer is defined by the abnormal and uncontrolled proliferation of cells. Transfection reagents play a crucial role in cancer research by introducing foreign genetic material, such as plasmid DNA or RNA molecules, allowing researchers to investigate various aspects of cancer biology, including gene expression studies, gene silencing, drug screening, and target validation. For instance, in April 2024, the American Cancer Society, a US-based non-profit organization, reported 20 million new cancer cases and 9.7 million deaths in 2022. Consequently, the increasing number of cancer patients worldwide is fueling the growth of the transfection reagents and equipment market.

The upward trajectory in healthcare expenditures is expected to fuel the growth of the transfection reagents and equipment market in the foreseeable future. Healthcare expenditures encompass all costs associated with delivering health services, family planning activities, nutrition programs, and emergency assistance with a focus on health. The increase in healthcare spending translates to higher investments in research and development, thereby boosting the demand for transfection reagents and equipment as indispensable tools for advancing genetic research, gene therapy, and biopharmaceutical development. For instance, as of June 2023, the Centers for Medicare & Medicaid Services, a US-based federal agency, reported a 2.7% increase in healthcare expenditure in the United States, totaling $4.3 trillion or $12,914 per person in 2021. This expenditure accounted for 18.3% of the nation's gross domestic product. Consequently, the surge in healthcare expenditures is a driving force behind the growth of the transfection reagents and equipment market.

A prominent trend gaining traction in the transfection reagents and equipment market is product innovation, with major companies strategically focusing on developing inventive products to maintain their market standing. An example of this is Polyplus-Transfection SA, a France-based biotechnology company, which, in September 2022, introduced the in vivo-jetRNA+ transfection reagent. This novel product utilizes a preformed liposome formulation for in vivo mRNA delivery, offering a highly efficient and scalable gene delivery system capable of delivering mRNA to diverse tissues and cell types. Notably safe and well-tolerated, the reagent eliminates the need for formulation stages, and its stable liposome size accommodates varying mRNA concentrations over time. Applications include prophylactic vaccinations, mRNA treatments (such as cancer therapy and rare diseases), and gene editing.

Major companies in the transfection reagents and equipment market are intensifying their efforts to introduce innovative product lines. Mirus Bio LLC, a US-based biotechnology company, exemplifies this approach with the launch of the TransIT-VirusGEN GMP product line in August 2022. This product line, designed for efficient and scalable transfection of viral vectors, supports GMP manufacturing processes in gene therapy applications. Specifically tailored for large-scale therapeutic production of adeno-associated virus (AAV) and lentivirus vectors, the TransIT-VirusGEN GMP Transfection Reagent serves as an ancillary material for various products, including cell, gene, and tissue-engineered products, meeting USP <1043 standards. The primary goal is to aid biopharmaceutical manufacturers in addressing challenges related to effectively and cost-effectively producing AAV and LV vectors with the requisite quality and volume for commercial viability.

In March 2023, Sartorius AG, a Germany-based analytical laboratory instrument manufacturing company, acquired Polyplus-Transfection SA for $2.6 billion. This acquisition positions Sartorius AG strongly in the rapidly expanding cell and gene therapy markets, supporting business growth and meeting the escalating demand for cell and gene therapies. Polyplus-Transfection SA, a France-based biotechnology company, specializes in the development of transfection reagents and equipment.

Major companies operating in the transfection reagents and equipment market include Thermo Fisher Scientific Inc., Promega Corporation, Qiagen N.V., Bio-Rad Laboratories Inc., Maxcyte Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., PromoCell GmbH, PerkinElmer Inc., Agilent Technologies Inc., Altogen Biosystems, Applied Biological Materials Inc., Bex Co. Ltd., Sartorius AG, Takara Bio Inc., Tecan Trading AG, Polyplus-transfection SA, Sigma-Aldrich Corporation, Hoffmann-La Roche Ltd., Transfection Technologies Inc., Viromer, ABM Inc., Bio-Techne Corporation, Biotium Inc., Cell Applications Inc., chemicell GmbH, Genlantis, Biontex Laboratories GmbH, Boca Scientific Inc., Jena Bioscience GmbH

North America was the largest region in the transfection reagents and equipment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection reagents and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the transfection reagents and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The transfection reagents and equipment market consists of sales of lipid-based transfection reagents, cationic polymer-based transfection reagents, calcium phosphate-based transfection reagents, viral transduction tools, transfection control plasmids, transfection validation tools, and electroporation systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transfection Reagents And Equipment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transfection reagents and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transfection reagents and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transfection reagents and equipment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Products: Instruments; Reagent And Kits
  • 2) By Types Of Molecule: Plasmid DNA; DNA Oligonucleotides; Small Interfering RNA (SiRNA); Proteins; Ribonucleoprotein Complexes (RNPs); Other Molecules
  • 3) By Organism: Bacteria; Mammalian Cells; Fungi; Plants; Virus
  • 4) By End User: Biopharma; Contract Research Organizations (CROs); Contract Manufacturing Organizations (CMOs) And Contract Development And Manufacturing Organizations (CDMOs); Academia; Hospitals; Clinical Labs; Other End Users
  • Subsegments:
  • 1) By Instruments: Electroporation Systems; Microinjection Systems; Particle Bombardment Systems; Other Instruments
  • 2) By Reagent And Kits: Lipid-Based Transfection Reagents; Polymer-Based Transfection Reagents; Protein-Based Transfection Reagents; Nucleic Acid Delivery Kits; Other Reagents And Kits
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Promega Corporation; Qiagen N.V.; Bio-Rad Laboratories Inc.; Maxcyte Inc.; Lonza Group Ltd.; Merck KGaA; Mirus Bio LLC; OriGene Technologies Inc.; PromoCell GmbH; PerkinElmer Inc.; Agilent Technologies Inc.; Altogen Biosystems; Applied Biological Materials Inc.; Bex Co. Ltd.; Sartorius AG; Takara Bio Inc.; Tecan Trading AG; Polyplus-transfection SA; Sigma-Aldrich Corporation; Hoffmann-La Roche Ltd.; Transfection Technologies Inc.; Viromer; ABM Inc.; Bio-Techne Corporation; Biotium Inc.; Cell Applications Inc.; chemicell GmbH; Genlantis; Biontex Laboratories GmbH; Boca Scientific Inc.; Jena Bioscience GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Transfection Reagents And Equipment Market Characteristics

3. Transfection Reagents And Equipment Market Trends And Strategies

4. Transfection Reagents And Equipment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Transfection Reagents And Equipment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Transfection Reagents And Equipment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Transfection Reagents And Equipment Market Growth Rate Analysis
  • 5.4. Global Transfection Reagents And Equipment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Transfection Reagents And Equipment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Transfection Reagents And Equipment Total Addressable Market (TAM)

6. Transfection Reagents And Equipment Market Segmentation

  • 6.1. Global Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagent And Kits
  • 6.2. Global Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Plasmid DNA
  • DNA Oligonucleotides
  • Small Interfering RNA (SiRNA)
  • Proteins
  • Ribonucleoprotein Complexes (RNPs)
  • Other Molecules
  • 6.3. Global Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacteria
  • Mammalian Cells
  • Fungi
  • Plants
  • Virus
  • 6.4. Global Transfection Reagents And Equipment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopharma
  • Contract Research Organizations (CROs)
  • Contract Manufacturing Organizations (CMOs) And Contract Development And Manufacturing Organizations (CDMOs)
  • Academia
  • Hospitals
  • Clinical Labs
  • Other End Users
  • 6.5. Global Transfection Reagents And Equipment Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electroporation Systems
  • Microinjection Systems
  • Particle Bombardment Systems
  • Other Instruments
  • 6.6. Global Transfection Reagents And Equipment Market, Sub-Segmentation Of Reagent And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lipid-Based Transfection Reagents
  • Polymer-Based Transfection Reagents
  • Protein-Based Transfection Reagents
  • Nucleic Acid Delivery Kits
  • Other Reagents And Kits

7. Transfection Reagents And Equipment Market Regional And Country Analysis

  • 7.1. Global Transfection Reagents And Equipment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Transfection Reagents And Equipment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Transfection Reagents And Equipment Market

  • 8.1. Asia-Pacific Transfection Reagents And Equipment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Transfection Reagents And Equipment Market

  • 9.1. China Transfection Reagents And Equipment Market Overview
  • 9.2. China Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Transfection Reagents And Equipment Market

  • 10.1. India Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Transfection Reagents And Equipment Market

  • 11.1. Japan Transfection Reagents And Equipment Market Overview
  • 11.2. Japan Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Transfection Reagents And Equipment Market

  • 12.1. Australia Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Transfection Reagents And Equipment Market

  • 13.1. Indonesia Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Transfection Reagents And Equipment Market

  • 14.1. South Korea Transfection Reagents And Equipment Market Overview
  • 14.2. South Korea Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Transfection Reagents And Equipment Market

  • 15.1. Western Europe Transfection Reagents And Equipment Market Overview
  • 15.2. Western Europe Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Transfection Reagents And Equipment Market

  • 16.1. UK Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Transfection Reagents And Equipment Market

  • 17.1. Germany Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Transfection Reagents And Equipment Market

  • 18.1. France Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Transfection Reagents And Equipment Market

  • 19.1. Italy Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Transfection Reagents And Equipment Market

  • 20.1. Spain Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Transfection Reagents And Equipment Market

  • 21.1. Eastern Europe Transfection Reagents And Equipment Market Overview
  • 21.2. Eastern Europe Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Transfection Reagents And Equipment Market

  • 22.1. Russia Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Transfection Reagents And Equipment Market

  • 23.1. North America Transfection Reagents And Equipment Market Overview
  • 23.2. North America Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Transfection Reagents And Equipment Market

  • 24.1. USA Transfection Reagents And Equipment Market Overview
  • 24.2. USA Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Transfection Reagents And Equipment Market

  • 25.1. Canada Transfection Reagents And Equipment Market Overview
  • 25.2. Canada Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Transfection Reagents And Equipment Market

  • 26.1. South America Transfection Reagents And Equipment Market Overview
  • 26.2. South America Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Transfection Reagents And Equipment Market

  • 27.1. Brazil Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Transfection Reagents And Equipment Market

  • 28.1. Middle East Transfection Reagents And Equipment Market Overview
  • 28.2. Middle East Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Transfection Reagents And Equipment Market

  • 29.1. Africa Transfection Reagents And Equipment Market Overview
  • 29.2. Africa Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Transfection Reagents And Equipment Market Competitive Landscape And Company Profiles

  • 30.1. Transfection Reagents And Equipment Market Competitive Landscape
  • 30.2. Transfection Reagents And Equipment Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Promega Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Qiagen N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Maxcyte Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Transfection Reagents And Equipment Market Other Major And Innovative Companies

  • 31.1. Lonza Group Ltd.
  • 31.2. Merck KGaA
  • 31.3. Mirus Bio LLC
  • 31.4. OriGene Technologies Inc.
  • 31.5. PromoCell GmbH
  • 31.6. PerkinElmer Inc.
  • 31.7. Agilent Technologies Inc.
  • 31.8. Altogen Biosystems
  • 31.9. Applied Biological Materials Inc.
  • 31.10. Bex Co. Ltd.
  • 31.11. Sartorius AG
  • 31.12. Takara Bio Inc.
  • 31.13. Tecan Trading AG
  • 31.14. Polyplus-transfection SA
  • 31.15. Sigma-Aldrich Corporation

32. Global Transfection Reagents And Equipment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Transfection Reagents And Equipment Market

34. Recent Developments In The Transfection Reagents And Equipment Market

35. Transfection Reagents And Equipment Market High Potential Countries, Segments and Strategies

  • 35.1 Transfection Reagents And Equipment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Transfection Reagents And Equipment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Transfection Reagents And Equipment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer